VICP Registry Case Source Bundle Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_15-vv-01120 Package ID: USCOURTS-cofc-1_15-vv-01120 Petitioner: Rachal Laprairie Filed: 2017-04-18 Decided: 2017-04-18 Vaccine: influenza Vaccination date: 2013-10-08 Condition: Guillain-Barré Syndrome (“GBS”) Outcome: compensated Award amount USD: 195000 AI-assisted case summary: On April 18, 2017, Rachal Lapairie filed a petition alleging Guillain-Barré Syndrome (GBS) as a result of receiving an influenza and tetanus-acellular pertussis (Tdap) vaccine on October 8, 2013. The respondent denied that the vaccines caused the petitioner's GBS or any other injury. The parties reached a stipulation to resolve the case, and the Special Master adopted the terms of this stipulation. The court awarded Rachal Lapairie $195,000.00 as a lump sum, representing compensation for all damages available under the program. The decision was issued by Special Master Laura D. Millman on April 18, 2017. The public decision does not describe the petitioner's specific symptoms, medical history, diagnostic tests, treatments, or the specific mechanism by which the vaccines allegedly caused the GBS. The names of the petitioner's counsel and respondent's counsel are listed as Craig S. Watson and Linda S. Renzi, respectively. Theory of causation field: Petitioner Rachal Lapairie alleged Guillain-Barré Syndrome (GBS) following receipt of an influenza and Tdap vaccine on October 8, 2013. Respondent denied causation. The parties reached a stipulation to resolve the case, and Special Master Laura D. Millman adopted the stipulation, awarding $195,000.00. The public decision does not detail the specific theory of causation, medical experts, or the mechanism of injury, stating only that the respondent denied causation. The award was a lump sum for all damages. Public staged source text: ================================================================================ DOCUMENT 1: USCOURTS-cofc-1_15-vv-01120-0 Date issued/filed: 2017-05-26 Pages: 7 Docket text: PUBLIC DECISION (Originally filed: 04/18/2017) regarding 27 DECISION Stipulation/Proffer Signed by Special Master Laura D Millman. (tlf) Copy to parties. -------------------------------------------------------------------------------- Case 1:15-vv-01120-UNJ Document 31 Filed 05/26/17 Page 1 of 7 In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 15-1120V Filed: April 18, 2017 Not for Publication ************************************* RACHAL LAPRAIRIE, * * Petitioner, * Damages decision based on * stipulation; Guillain-Barré v. * Syndrome (“GBS”); influenza * (“flu”) vaccine; tetanus-acellular SECRETARY OF HEALTH * pertussis (“Tdap”) vaccine AND HUMAN SERVICES, * * Respondent. * * ************************************* Craig S. Watson, Baton Rouge, LA, for petitioner. Linda S. Renzi, Washington, DC, for respondent. MILLMAN, Special Master DECISION AWARDING DAMAGES1 On April 18, 2017, the parties filed the attached stipulation in which they agreed to settle this case and described the settlement terms. Petitioner alleges he suffered Guillain-Barré Syndrome (“GBS”) as a result of his October 8, 2013 receipt of the influenza (“flu”) and tetanus- acellular pertussis (“Tdap”) vaccines. Respondent denies that either the flu or Tdap vaccine caused petitioner’s GBS or any other injury. Nonetheless, the parties agreed to resolve this matter informally. 1 Because this unpublished decision contains a reasoned explanation for the special master’s action in this case, the special master intends to post this unpublished decision on the United States Court of Federal Claims’ website, in accordance with the E-Government Act of 2002, 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government Services). Vaccine Rule 18(b) states that all decisions of the special masters will be made available to the public unless they contain trade secrets or commercial or financial information that is privileged and confidential, or medical or similar information whose disclosure would constitute a clearly unwarranted invasion of privacy. When such a decision is filed, petitioner has 14 days to identify and move to redact such information prior to the document=s disclosure. If the special master, upon review, agrees that the identified material fits within the banned categories listed above, the special master shall redact such material from public access. Case 1:15-vv-01120-UNJ Document 31 Filed 05/26/17 Page 2 of 7 The undersigned finds the terms of the stipulation to be reasonable. The court adopts the parties’ stipulation, attached, and awards compensation in the amount and on the terms set forth in the stipulation. Pursuant to the stipulation, the court awards a lump sum of $195,000.00, representing reimbursement for all damages that would be available under 42 U.S.C. § 300aa- 15(a) (2012). The award shall be in the form of a check payable to petitioner in the amount of $195,000.00. In the absence of a motion for review filed pursuant to RCFC Appendix B, the clerk of the court is directed to enter judgment herewith.2 IT IS SO ORDERED. Dated: April 18, 2017 s/ Laura D. Millman Laura D. Millman Special Master 2 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by each party, either separately or jointly, filing a notice renouncing the right to seek review. 2 Case 1:15-vv-01120-UNJ Document 31 Filed 05/26/17 Page 3 of 7 Case 1:15-vv-01120-UNJ Document 31 Filed 05/26/17 Page 4 of 7 Case 1:15-vv-01120-UNJ Document 31 Filed 05/26/17 Page 5 of 7 Case 1:15-vv-01120-UNJ Document 31 Filed 05/26/17 Page 6 of 7 Case 1:15-vv-01120-UNJ Document 31 Filed 05/26/17 Page 7 of 7